Company intelligence / Profile preview

NuXcel

Ireland

Ownership: Private
Development stage: Other

Overview

NuXcel is a medical device accelerator that incubates and spins off companies rather than developing clinical programs directly. The company has successfully spun off three startups in neuromodulation: ShiraTronics (clinical stage, US FDA trial in progress for chronic migraine), Avivomed (clinical stage, feasibility trial in progress), and iVEAcare (currently under stealth mode). These three spin-offs have collectively raised approximately $100M in Series A financings.

Modalities: Device
Industry: Investors

Beyond the preview

Go deeper on NuXcel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NuXcel.

Explore the full profile